Explore the words cloud of the ALTER-brain project. It provides you a very rough idea of what is the project "ALTER-brain" about.
The following table provides information about the project.
Coordinator |
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III
Organization address contact info |
Coordinator Country | Spain [ES] |
Total cost | 1˙897˙437 € |
EC max contribution | 1˙897˙437 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2019-COG |
Funding Scheme | ERC-COG |
Starting year | 2020 |
Duration (year-month-day) | from 2020-07-01 to 2025-06-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III | ES (MADRID) | coordinator | 1˙897˙437.00 |
Organ colonization is the most inefficient step of metastasis. However, once a few cancer cells manage to re-initiate their growth in the brain, the initial naïve microenvironment, which was not favouring and even actively limiting the number of potential metastasis initiating cells, is slowly rewired into a different ecosystem with pro-metastatic properties. In this project (ALTER-brain), we will study the biology of microenvironment reprogramming to explore innovative ways of treating metastasis. Microenvironment reprogramming relies on altered molecular patterns that emerge in specific brain cell types simultaneously to the outgrowth of metastases. Dissecting the biology of these emerging patterns and their functional consequences could provide the basis to prevent metastasis but also to treat advances lesions. A key objective of ALTER-brain is the identification of newly established functional networks among previously non-connected components of the microenvironment that are critical to nurture tumour growth. This research proposal focuses on metastasis in the brain given its rising incidence, poor therapeutic options and short survival rates upon diagnosis. ALTER-brain will use novel (i.e. spontaneous metastasis) and clinically relevant (i.e. relapse after therapy) experimental mouse models of brain metastasis combined with genetically engineered mice in which we will target specific components of the microenvironment. In addition, we will apply novel lineage tracing technologies to understand the origin and emerging heterogeneity of the reprogrammed microenvironment. Given the clinical relevance of our research, human brain metastasis provided by our clinical network will be used to validate key findings. ALTER-brain will identify key principles underlying the unknown biology of the brain under a specific pathological pressure that might be translated to other highly prevalent disorders affecting this organ in the future.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALTER-BRAIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ALTER-BRAIN" are provided by the European Opendata Portal: CORDIS opendata.
Why is the world green: testing top-down control of plant-herbivore food webs by experiments with birds, bats and ants
Read MoreHigh-throughput single-cell phenotypic analysis of functional antibody repertoires
Read MoreUnderstanding DSB repair from pathway choice to long term effects and their consequences.
Read More